Toxicologic Pathology

Toxicologic Pathology – Recent articles

• Hemangiosarcomas in Intercostal Brown Adipose Tissues of the Sternum Induced by Urethane in TgrasH2 Mice
  June 4, 2026 by Maodong Zhang, Predrag Novakovic, Joseph Younan, Lev Kolodzieyski
• Adeno-Associated Virus Gene Therapy: Is There a Risk of Insertional Mutagenesis?
  May 31, 2026 by Paul Batty
• Imatinib-Induced Hemorrhage in the Corpus Luteum Is Attenuated in Pseudopregnant and Hypophysectomized Rats
  May 19, 2026 by Yuki Numakura, Fumiya Ishizuka, Yuki Tsukamoto, Takashi Kotera, Keiichi Asakura
• Select Histochemical and Immunohistochemical Methods to Investigate the Cell and Tissue Composition of the Mouse Placenta and Metrial Gland
  May 15, 2026 by Susan A. Elmore, Robert Z. Cochran, Charan Ganta, Heather Jensen, Beth A. Lubeck, Beth Mahler, David Sabio, Greg Stamper, Brad Bolon
• Placental Lesions in CD-1 Mouse Placenta Following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)
  May 14, 2026 by Julie F. Foley, Catherine A. Picut, Vesna A. Chappell, Colette N. Miller, Suzanne E. Fenton, Bevin E. Blake
• Injection-Site Sarcomas in Rodent Carcinogenicity Studies: Human Relevance and Labeling Implications
  May 12, 2026 by Bhanu Singh, Doris Zane, Jim Hartke
• Absolute Versus Relative Approaches to Severity Scoring of Histopathologic Findings in Pre-Clinical Toxicology Studies: What’s the Difference, and How, When, and Why This Matters
  May 10, 2026 by Jeffrey C. Wolf, Kathleen A. Funk
• Toxicologic Pathology Forum Opinion*: In Defense of Scientific Freedom
  May 9, 2026 by Rani S. Sellers, Richard A. Peterson, Brad Bolon
• Carcinogenicity Risk Assessment of Targeted Protein Degraders
  April 29, 2026 by James Sidaway, Emily E Meseck
• Carcinogenicity in the 21st Century: Data Interpretation—Session 4
  April 8, 2026 by Sandra De Jonghe, Matthew Jacobsen, Jim Saul, Alys Bradley, John R Foster, Zuhal Dincer, Ute Bach, Tanasa Osborne